Product Code: GVR-2-68038-323-2
Urology Surgical Instruments Market Growth & Trends
The global urology surgical instruments market size is expected to reach USD 20.36 billion by 2030, registering a CAGR of 8.1%, according to a new report by Grand View Research, Inc. Growing geriatric population, increasing prevalence of urinary disorders, rising preference for minimally invasive surgeries, surging R&D investments, and ongoing product launches by manufacturers are some of the key factors driving this market.
According to the National Association for Continence, one in five individuals over the age of 40 suffers from urine urgency, overactive bladder, or leakage of urine. Urinary incontinence is highly prevalent among geriatric population and often results in poor quality of life, high costs, and morbidity. As per the American Society of Nephrology, urologic issues are the third most common complaint among people 65 years and above and they account for approximately 47.0% of visits to the physician. Thus, rising geriatric population could lead to increase in prevalence of urinary problems, thereby boosting demand for urology surgical instruments in the coming years.
There has been growing preference for minimally invasive surgeries (MIS) in gynecology and urology in recent years. Many manufacturers are focusing on development of products to be used for such procedures. For instance, in FY 2017, the research and development expenses of Olympus Corporation were pegged at USD 355.21 million. Similarly, the R&D costs of Coloplast in 2016/17 were nearly USD 94.08 million (DKK 574 million). This has increased from USD 83.43 million (DKK 509 million) in 2015/16. These R&D investments aid in development and launch of new products in the market.
Urology Surgical Instruments Market Report Highlights
- By product, the consumables and accessories segment held majority of the market in 2022 due to repeated usage of these products and their disposable nature
- On the basis of application, chronic kidney diseases (CKD) held the dominant share in 2022 owing to rise in cases of CKD, increasing number of clinical trials for new non-invasive procedures to treat these conditions, and initiatives by governments across the globe
- North America dominated the global market owing to an increase in demand for minimally invasive urology surgeries, positive reimbursement scenario, and high adoption of advanced technologies
- Asia Pacific is anticipated to witness the fastest growth owing to improving healthcare infrastructure, rising prevalence of urology disorders, and growing popularity of this region as a destination for medical tourism
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Urology Surgical Instruments Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Reimbursement framework
- 3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.2. Market restraint analysis
- 3.5. Urology Surgical Instruments Market Analysis Tools
- 3.5.1. Industry Analysis - Porter's
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. The threat of new entrants
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic landscape
Chapter 4. Urology Surgical Instruments: Product Estimates & Trend Analysis
- 4.1. Urology Surgical Instruments Market: Key Takeaways
- 4.2. Urology Surgical Instruments Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Endoscopes
- 4.3.1. Endoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Envision Systems
- 4.4.1. Envision systems market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5. Peripheral Systems
- 4.5.1. Peripheral systems market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6. Accessories & Consumables
- 4.6.1. Accessories & consumables market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Urology Surgical Instruments: Application Estimates & Trend Analysis
- 5.1. Urology Surgical Instruments Market: Key Takeaways
- 5.2. Urology Surgical Instruments Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Chronic Kidney Disease
- 5.3.1. Chronic kidney disease market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4. Benign Prostatic Hyperplasia (BPH)
- 5.4.1. Benign Prostatic Hyperplasia (BPH) market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. Urinary Stones
- 5.5.1. Urinary stones market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.6. Urinary Incontinence (UI) and Pelvic Organ Prolapse (POP)
- 5.6.1. Urinary Incontinence (UI) and Pelvic Organ Prolapse (POP) market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.7. Oncology
- 5.7.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.8. Other Applications
- 5.8.1. Other applications market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Urology Surgical Instruments Market: Regional Estimates & Trend Analysis
- 6.1. Regional Outlook
- 6.2. Urology Surgical Instruments Market by Region: Key Marketplace Takeaway
- 6.3. North America
- 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.2. U.S.
- 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.3. Canada
- 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4. Europe
- 6.4.1. UK
- 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.2. Germany
- 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.3. France
- 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.4. Italy
- 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.5. Spain
- 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.6. Sweden
- 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.7. Norway
- 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.8. Denmark
- 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5. Asia Pacific
- 6.5.1. Japan
- 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.2. China
- 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.3. India
- 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.4. Australia
- 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.5. Thailand
- 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.6. South Korea
- 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6. Latin America
- 6.6.1. Brazil
- 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.2. Mexico
- 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.3. Argentina
- 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7. MEA
- 6.7.1. Saudi Arabia
- 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.2. South Africa
- 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.3. UAE
- 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.4. Kuwait
- 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Market Participant Categorization
- 7.2.1. Medtronic
- 7.2.1.1. Company overview
- 7.2.1.2. Financial performance
- 7.2.1.3. Product benchmarking
- 7.2.1.4. Strategic initiatives
- 7.2.2. Boston scientific corporation
- 7.2.2.1. Company overview
- 7.2.2.2. Financial performance
- 7.2.2.3. Product benchmarking
- 7.2.2.4. Strategic initiatives
- 7.2.3. Olympus Corporation
- 7.2.3.1. Company overview
- 7.2.3.2. Financial performance
- 7.2.3.3. Product benchmarking
- 7.2.3.4. Strategic initiatives
- 7.2.4. Karl Storz GmbH & Co. KG
- 7.2.4.1. Company overview
- 7.2.4.2. Financial performance
- 7.2.4.3. Product benchmarking
- 7.2.4.4. Strategic initiatives
- 7.2.5. Cook Medical LLC
- 7.2.5.1. Company overview
- 7.2.5.2. Financial performance
- 7.2.5.3. Product benchmarking
- 7.2.5.4. Strategic initiatives
- 7.2.6. Richard Wolf GmbH
- 7.2.6.1. Company overview
- 7.2.6.2. Financial performance
- 7.2.6.3. Product benchmarking
- 7.2.6.4. Strategic initiatives
- 7.2.7. Stryker
- 7.2.7.1. Company overview
- 7.2.7.2. Financial performance
- 7.2.7.3. Product benchmarking
- 7.2.7.4. Strategic initiatives
- 7.2.8. Teleflex Incorporated
- 7.2.8.1. Company overview
- 7.2.8.2. Financial performance
- 7.2.8.3. Product benchmarking
- 7.2.8.4. Strategic initiatives
- 7.2.9. Coloplast Group
- 7.2.9.1. Company overview
- 7.2.9.2. Financial performance
- 7.2.9.3. Product benchmarking
- 7.2.9.4. Strategic initiatives